(Q40357899)

19 September 2017

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus (English)

1 reference

19 September 2017

1 reference

1 reference

11

Kazuaki Chayama

1 reference

19 September 2017

6

Michio Imamura

1 reference

19 September 2017

1

Masataka Tsuge

1 reference

19 September 2017

7

Shoichi Takahashi

1 reference

19 September 2017

10

Hidenori Ochi

1 reference

19 September 2017

2

Nobuhiko Hiraga

1 reference

19 September 2017

Hideki Takaishi

3

1 reference

19 September 2017

Chiemi Noguchi

4

1 reference

19 September 2017

Hiromi Oga

5

1 reference

19 September 2017

Eiji Iwao

8

1 reference

19 September 2017

Yoshifumi Fujimoto

9

1 reference

19 September 2017

Chise Tateno

12

1 reference

19 September 2017

Katsutoshi Yoshizato

13

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

19 September 2017

1 reference

19 September 2017

42

1 reference

19 September 2017

5

1 reference

19 September 2017

1046-1054

1 reference

Near completely humanized liver in mice shows human-type metabolic responses to drugs

19 September 2017

1 reference

Clinical aspects of hepatitis B virus infection

21 January 2018

1 reference

7 January 2021

Hepatitis B virus and hepatocellular carcinoma

1 reference

7 January 2021

Clinical virology of hepatitis B virus infection

1 reference

7 January 2021

Hepatitis B virus infection--natural history and clinical consequences

1 reference

7 January 2021

In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees

1 reference

7 January 2021

Chimpanzee models for human disease and immunobiology

1 reference

7 January 2021

A critical role for the chimpanzee model in the study of hepatitis C.

1 reference

7 January 2021

High-level hepatitis B virus replication in transgenic mice

1 reference

7 January 2021

Transcriptional and posttranscriptional control of hepatitis B virus gene expression

1 reference

7 January 2021

Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B

1 reference

7 January 2021

Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model

1 reference

7 January 2021

The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.

1 reference

7 January 2021

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

1 reference

7 January 2021

A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice

1 reference

7 January 2021

Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma

1 reference

7 January 2021

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

1 reference

7 January 2021

Hepatitis C virus replication in mice with chimeric human livers

1 reference

7 January 2021

Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations.

1 reference

7 January 2021

Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle

1 reference

7 January 2021

Cloned HBV DNA causes hepatitis in chimpanzees

1 reference

7 January 2021

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

1 reference

7 January 2021

The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees

1 reference

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

7 January 2021

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

7 January 2021

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20892

1 reference

19 September 2017

1 reference